A detailed history of Transcend Capital Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Transcend Capital Advisors, LLC holds 8,406 shares of GILD stock, worth $789,743. This represents 0.05% of its overall portfolio holdings.

Number of Shares
8,406
Previous 8,317 1.07%
Holding current value
$789,743
Previous $570,000 23.51%
% of portfolio
0.05%
Previous 0.04%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$66.59 - $83.99 $5,926 - $7,475
89 Added 1.07%
8,406 $704,000
Q2 2024

Jul 02, 2024

BUY
$63.15 - $72.88 $2,841 - $3,279
45 Added 0.54%
8,317 $570,000
Q1 2024

May 03, 2024

BUY
$71.58 - $87.29 $115,530 - $140,886
1,614 Added 24.24%
8,272 $605,000
Q4 2023

Feb 05, 2024

BUY
$73.27 - $83.09 $5,275 - $5,982
72 Added 1.09%
6,658 $539,000
Q3 2023

Oct 31, 2023

BUY
$73.94 - $80.67 $36,230 - $39,528
490 Added 8.04%
6,586 $493,000
Q2 2023

Jul 13, 2023

BUY
$76.01 - $86.7 $7,220 - $8,236
95 Added 1.58%
6,096 $469,000
Q1 2023

Apr 12, 2023

SELL
$77.31 - $88.08 $1.47 Million - $1.67 Million
-18,980 Reduced 75.98%
6,001 $497,000
Q4 2022

Jan 20, 2023

SELL
$62.32 - $89.47 $95,972 - $137,783
-1,540 Reduced 5.81%
24,981 $0
Q3 2022

Oct 17, 2022

BUY
$59.54 - $68.01 $30,365 - $34,685
510 Added 1.96%
26,521 $1.64 Million
Q2 2022

Jul 12, 2022

BUY
$57.72 - $65.01 $5,079 - $5,720
88 Added 0.34%
26,011 $1.61 Million
Q1 2022

Apr 20, 2022

BUY
$57.92 - $72.58 $480,504 - $602,123
8,296 Added 47.06%
25,923 $1.54 Million
Q3 2021

Nov 04, 2021

SELL
$67.69 - $73.03 $8,664 - $9,347
-128 Reduced 0.72%
17,627 $1.19 Million
Q2 2021

Aug 13, 2021

SELL
$63.47 - $69.35 $14,598 - $15,950
-230 Reduced 1.28%
17,755 $1.22 Million
Q1 2021

May 12, 2021

SELL
$60.0 - $68.46 $135,660 - $154,788
-2,261 Reduced 11.17%
17,985 $1.16 Million
Q4 2020

Feb 12, 2021

SELL
$56.65 - $64.55 $1,076 - $1,226
-19 Reduced 0.09%
20,246 $1.18 Million
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $287,336 - $361,276
4,627 Added 29.59%
20,265 $1.28 Million
Q2 2020

Aug 05, 2020

SELL
$72.34 - $84.0 $286,032 - $332,136
-3,954 Reduced 20.18%
15,638 $1.2 Million
Q1 2020

May 08, 2020

BUY
$62.63 - $80.22 $1.23 Million - $1.57 Million
19,592 New
19,592 $1.47 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Transcend Capital Advisors, LLC Portfolio

Follow Transcend Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transcend Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transcend Capital Advisors, LLC with notifications on news.